GSE128054
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway
This study first reveals that MYT1 is a potential oncogene in neuroblastoma, which is significantly correlated with poor prognosis and represses cellular differentiation via interrupting retinoic acid signaling pathway. Overall design: MYT1 knockout was performed in neuroblastoma cell line SK-N-BE(2)